Clarkson C W, Hondeghem L M
Anesthesiology. 1985 Apr;62(4):396-405.
The effects of bupivacaine and lidocaine on cardiac conduction were compared in guinea pig ventricular muscle. Membrane potential was controlled using a single sucrose gap voltage clamp technique, and the maximum upstroke velocity of the action potential (Vmax) was used as an indicator of peak sodium current. Bupivacaine blocked cardiac sodium channels in a time- and voltage-dependent fashion. Although bupivacaine has a low affinity for rested and activated sodium channels, it avidly blocks inactivated channels (Kd = 9 X 10(-7) M). Bupivacaine-associated channels do not conduct and have their voltage dependence of inactivation shifted by about 33 mV to more negative potentials. At bupivacaine concentrations above 0.2 micrograms/ml, a substantial fraction of the channels become blocked during the cardiac action potential, while recovery from block during diastole proceeds relatively slowly with a time constant (tau) of 1,557 +/- 304 ms (n = 8). Thus, bupivacaine blocks sodium channels in a fast-in-slow-out fashion, and substantial block accumulates at 60-150 beats/min. In comparison, 5-10 micrograms/ml lidocaine also blocks a substantial fraction of channels during the action potential, but diastolic recovery from block is more rapid (tau = 153.8 +/- 51.2 ms, n = 4). Thus, lidocaine blocks channels in a fast-in-fast-out fashion. Consequently, even at toxic doses of lidocaine (i.e., 10 micrograms/ml), little accumulation of block occurs at normal heart rates. Sodium channel block by bupivacaine can be minimized by reducing heart rate, hyperpolarization, and shortening of action potential duration. However, alteration of these variables over clinically applicable ranges does not produce marked changes in bupivacaine effect. Our results provide a possible explanation for the clinical observation that when bupivacaine accidently gains access to the general circulation, cardiac conduction can be depressed seriously and such depression may be difficult to reverse.
在豚鼠心室肌中比较了布比卡因和利多卡因对心脏传导的影响。使用单蔗糖间隙电压钳技术控制膜电位,并将动作电位的最大上升速度(Vmax)用作峰值钠电流的指标。布比卡因以时间和电压依赖性方式阻断心脏钠通道。虽然布比卡因对静息和激活的钠通道亲和力较低,但它能强烈阻断失活通道(解离常数Kd = 9×10⁻⁷ M)。与布比卡因相关的通道不传导,其失活的电压依赖性向更负的电位偏移约33 mV。在布比卡因浓度高于0.2微克/毫升时,相当一部分通道在心脏动作电位期间被阻断,而在舒张期从阻断中恢复相对较慢,时间常数(τ)为1557±304毫秒(n = 8)。因此,布比卡因以快进慢出的方式阻断钠通道,在60 - 150次/分钟时会积累大量阻断。相比之下,5 - 10微克/毫升的利多卡因在动作电位期间也会阻断相当一部分通道,但从阻断中舒张期恢复更快(τ = 153.8±5151.2毫秒,n = 4)。因此,利多卡因以快进快出的方式阻断通道。因此,即使在利多卡因的中毒剂量(即10微克/毫升)下,在正常心率下阻断的积累也很少。降低心率、超极化和缩短动作电位持续时间可使布比卡因引起的钠通道阻断最小化。然而,在临床适用范围内改变这些变量不会使布比卡因的作用产生明显变化。我们的结果为临床观察提供了一个可能的解释,即当布比卡因意外进入体循环时,心脏传导可能会严重受抑制,且这种抑制可能难以逆转。